U.S. STOCKS ON THE MOVE-Tenet, SLB, Digital Realty
BUZZ-U.S. STOCKS ON THE MOVE-Tenet, SLB, Digital Realty July 24 (Reuters) - Wall Street's major indexes rose on Friday but remained on track for weekly losses, as investors weighed a busy slate of corporate earnings, escalating Middle East tensions and new tariffs announced by the Trump administration. .N
At 13:30 EDT, the Dow Jones Industrial Average .DJI was up 0.59% at 52,018.25. The S&P 500 .SPX was up 0.45% at 7,441.34, and the Nasdaq Composite .IXIC was down 0.00% at 25,140.33.
The top three S&P 500 .PG.INX percentage gainers:
** Digital Realty Trust Inc DLR.N, up 13.6%
** SLB NV SLB.N, up 10.4%
** Equinix Inc EQIX.O, up 6.5%
The top three S&P 500 .PL.INX percentage losers:
** CH Robinson Worldwide Inc CHRW.OQ, down 8.3%
** Coherent Corp COHR.N, down 7.5%
** Sandisk Corp SNDK.O, down 7.0%
The top three NYSE .PG.N percentage gainers:
** LiveWire Group Inc LVWR.N, up 81.8%
** RingCentral Inc RNG.N, up 24.6%
** Tenet Healthcare Corp THC.N, up 16.4%
The top three NYSE .PL.N percentage losers:
** Hims & Hers Health Inc HIMS.N, down 12.5%
** Liberty Energy Inc LBRT.N, down 11.3%
** T1 Energy Inc TE.N, down 10.9%
The top three Nasdaq .PG.O percentage gainers:
** Ohmyhome Ltd OMH.O, up 107.4%
** STAK Inc STAK.O, up 84.8%
** Safety Insurance Group Inc SAFT.O, up 41.3%
The top three Nasdaq .PL.O percentage losers:
** China SXT Pharmaceuticals Inc SXTC.O, down 81.9%
** C3is Inc CISS.O, down 49.0%
** Vestand Inc VSTD.O, down 45.0%
** Deckers Outdoor Corp DECK.N:
BUZZ - Falls after maintaining annual sales forecast nL6N43Q0X1
** American Express Co AXP.N:
BUZZ - Falls as investors look past Q2 profit beat nL6N43Q0TE
** Tenet Healthcare Corp THC.N:
BUZZ - Jumps after lifting annual forecast nL4N43Q0TL
** Intel Corp INTC.O:
BUZZ - Drops despite blowout report; chip index retreats on Friday nL6N43Q133
** MannKind Corp MNKD.O:
BUZZ - Climbs as FDA approves drug-device combo for fluid buildup nL4N43Q0VH
** Verizon Communications Inc VZ.N:
BUZZ - Rises after raising annual profit forecast nL4N43Q0T4
** SLB NV SLB.N:
BUZZ - Gains on second-quarter profit beat nL4N43Q165
** Summit Therapeutics Inc SMMT.O:
BUZZ - Falls after share sale plans, Q2 report nL6N43Q0RJ
** Codexis Inc CDXS.O:
BUZZ - Plunges on deep-discounted stock offering nL6N43Q0S6
** Booz Allen Hamilton Corp BAH.N:
BUZZ - Gains after quarterly profit beat estimates nL6N43Q0SA
** Scribe Therapeutics Inc SCTX.O:
BUZZ - Set for New York debut after upsized $128.7 million IPO nL6N43Q0SY
** Newmont Corp NEM.N:
** AngloGold Ashanti PLC AU.N:
** Gold Fields Ltd GFI.N:
** Harmony Gold Mining Co Ltd HMY.N:
BUZZ - Gold miners advance as bullion back in positive territory nL4N43Q109
** Zevra Therapeutics Inc ZVRA.O:
BUZZ - Tanks after EU panel's negative opinion on rare disease drug nL4N43Q112
** Sensient Technologies Corp SXT.N:
BUZZ - Gains after Q2 results beat nL4N43Q12C
** Amkor Technology Inc AMKR.O:
BUZZ - Soars on Nvidia chip packaging deal nL6N43Q0UN
** Digital Realty Trust Inc DLR.N:
BUZZ - Eyes best day in 17 years on upbeat outlook nL6N43Q0Y6
Index RIC | Index name | Percent change % |
.SPX | S&P 500 | 0.45 |
.SPLRCT | S&P 500 Information Technology | 0.13 |
.SPLRCU | S&P 500 Utilities | 0.08 |
.SPLRCD | S&P 500 Consumer Discretionary | 0.23 |
.SPLRCM | S&P 500 Materials | 1.15 |
.SPLRCI | S&P 500 Industrials | 0.68 |
.SPLRCL | S&P 500 Communication Services (Sector) | 0.79 |
.SPSY | S&P 500 Financials | 0.53 |
.SPLRCR | S&P 500 Real Estate | 2.46 |
.SPXHC | S&P 500 Health Care | 0.7 |
.SPLRCS | S&P 500 Consumer Staples | 0.72 |
.SPNY | S&P 500 Energy | 0.31 |
(Rajarshi Roy and Prathik Jayaprakash)
((Rajarshi.Roy@thomsonreuters.com Prathik.Jayaprakash@thomsonreuters.com))
Recent news on Summit Therapeutics
See all newsBrief: Akeso Announces Summit Therapeutics And Ecog-Acrin Cancer Research Group Enter Into Phase Ii/Iii Clinical Trial Collaboration To Evaluate Ivonescimab In First-Line Biliary Tract Cancer
Factbox: Major drugmakers turn to China for licensing deals
Brief: Summit Therapeutics Announces Opening Of Global Phase Ii Study Of Ivonescimab-Based Regimens In Advanced Clear Cell Renal Cell Carcinoma
Factbox: Major drugmakers turn to China for licensing deals
AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination (updated)